SCHEMBL21160460

SCHEMBL21160460

CN(CCO)c1ccc2ncoc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.43
LMNA P02545 1/20 0.41
EGFR P00533 1/20 0.40
MAP4K4 O95819 2/20 0.39
MAPT P10636 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
DYRK1A Q13627 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
P2RX4 Q99571 3/20 0.36
NTSR1 P30989 2/20 0.35
POLB P06746 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYBB P04839 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24999939 0.80 DYRK1A (0.46) PDE10ALMNAEGFRTAS1R3TAS1R1
SCHEMBL24089678 0.72 EGFR (0.42) EGFRMAP4K4MAPTALDH1A1L3MBTL1
SCHEMBL21036961 0.71 MAPT (0.36) LMNAEGFRMAP4K4MAPTNPC1
SCHEMBL61067 0.71 MAPT (0.50) EGFRMAP4K4MAPTNPC1RAB9A
SCHEMBL21160451 0.70 PDE10A (0.43) PDE10ALMNAEGFRMAP4K4MAPT
SCHEMBL11437866 0.70 KDM4E (0.48) EGFRMAPTSMN1; SMN2POLBMEN1
SCHEMBL11781285 0.69 DYRK1A (0.40) PDE10ALMNATAS1R3TAS1R1DYRK1A
SCHEMBL14557292 0.69 ALDH1A1 (0.43) PDE10ALMNAMAPTTAS1R3TAS1R1
SCHEMBL14921136 0.68 ALDH1A1 (0.52) MAPTPOLBALDH1A1GAAL3MBTL1
SCHEMBL6598569 0.68 MEN1 (0.47) LMNATAS1R3TAS1R1DYRK1ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11209437-B2 Fluorescent probe and preparation method and use thereof FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) 2021-12-28 US disclosed
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-08-06 US disclosed
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF HNRNPF, HNRNPUL2, RAB5IF PDE10A 3340/4885LMNA 257/4885EGFR 3881/4885
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF WASF2, FAM162A, HASPIN PDE10A 3370/4885LMNA 1071/4885EGFR 4526/4885
US-11209437-B2 Fluorescent probe and preparation method and use thereof HNRNPF, HNRNPUL2, RAB5IF PDE10A 3340/4885LMNA 257/4885EGFR 3881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.